These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Chen MF; Shimada F; Kato H; Yano S; Kanaoka M Endocrinol Jpn; 1990 Jun; 37(3):331-41. PubMed ID: 2253583 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661 [TBL] [Abstract][Full Text] [Related]
10. Prednisolone concentrations in plasma, saliva and urine. Chakraborty J; Hayes M; English J; Baylis M; Marks V Eur J Clin Pharmacol; 1981 Jan; 19(1):79-81. PubMed ID: 7461028 [TBL] [Abstract][Full Text] [Related]
11. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults. Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369 [TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses. Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate. Möllmann H; Rohdewald P; Barth J; Verho M; Derendorf H Biopharm Drug Dispos; 1989; 10(5):453-64. PubMed ID: 2804250 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose. McAllister WA; Winfield CR; Collins JV Eur J Clin Pharmacol; 1981; 20(2):141-5. PubMed ID: 7262175 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. II. PSL pharmacokinetics during intermittent treatment with PSL administration 4 consecutive days a week]. Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):675-94. PubMed ID: 3622862 [TBL] [Abstract][Full Text] [Related]
16. Comparison of prednisolone kinetics in patients receiving daily or alternate-day prednisone for asthma. Greenberger PA; Chow MJ; Atkinson AJ; Ambre JJ; Patterson R Clin Pharmacol Ther; 1986 Feb; 39(2):163-8. PubMed ID: 3943272 [TBL] [Abstract][Full Text] [Related]
17. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Chen MF; Shimada F; Kato H; Yano S; Kanaoka M Endocrinol Jpn; 1991 Apr; 38(2):167-74. PubMed ID: 1752235 [TBL] [Abstract][Full Text] [Related]
18. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives. Olivesi A Biomed Pharmacother; 1986; 40(8):301-8. PubMed ID: 3814762 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration. Bergrem H; Grøttum P; Rugstad HE Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855 [TBL] [Abstract][Full Text] [Related]